HKSE - Delayed Quote HKD
JACOBIO-B (1167.HK)
3.960
+0.320
+(8.79%)
At close: May 9 at 4:08:05 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-74,120
-74,120
-364,199
-292,418
-147,492
Investing Cash Flow
256,224
256,224
-47,385
-686,322
161,667
Financing Cash Flow
21,281
21,281
245,662
-9,854
109,057
End Cash Position
677,092
677,092
469,155
624,375
1,527,204
Capital Expenditure
-12,090
-12,090
-38,660
-16,506
-11,135
Issuance of Capital Stock
0
0
139,137
0
132,831
Issuance of Debt
87,702
87,702
73,616
0
--
Repayment of Debt
-89,258
-89,258
0
--
--
Repurchase of Capital Stock
-4,565
-4,565
-5,682
0
-11,892
Free Cash Flow
-86,210
-86,210
-402,859
-308,924
-158,627
12/31/2021 - 12/21/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
9966.HK Alphamab Oncology
7.340
+2.37%
6955.HK Shandong Boan Biotechnology Co., Ltd.
9.370
-1.78%
9995.HK RemeGen Co., Ltd.
37.450
-3.48%
1875.HK TOT BIOPHARM-B
1.880
-1.05%
1541.HK IMMUNEONCO-B
6.440
+0.78%
2137.HK Brii Biosciences Limited
1.900
-1.04%
1530.HK 3SBIO
12.080
+4.50%
0775.HK CKLIFE SCIENCES
0.840
-2.33%
UPB Upstream Bio, Inc.
8.82
-0.23%
SEPN Septerna, Inc.
6.69
-3.74%